Cancer
biomarkers are the molecules secreted by a tumor or a specific response of
the human body indicating the presence of cancer. The biomarkers enable cancer
detection at an early stage and facilitate high-speed noninvasive diagnosis
using various genomics and proteomics tools. Cancer biomarkers are used for
various applications such as cancer diagnostics, drug discovery and
development, prognostics, personalized medicine, and surrogate endpoints. Over
the years, cancer biomarkers have become an integral part of research in
pharmaceutical and clinical trial companies, as they help to reduce the time
and cost of the drug discovery and development process.
Global Cancer
Biomarkers Market is expected to rise from its initial estimated value of USD
21.85 billion in 2018 to an estimated value of USD 56.06 billion by 2026,
registering a CAGR of 12.5% in the forecast period of 2019-2026. This rise in
market value can be attributed to the increasing Use of Cancer Biomarkers in
Drug Discovery and Development.
Download PDF Sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-biomarkers-market
Top Market Competitors: Global Cancer
Biomarkers Market
Few of the major competitors currently working in the Cancer
Biomarkers market are Abbott (U.S), DiagnoCure Inc ( Canada)., Affymetrix, Inc.
(U.S), Illumina, Inc.(U.S.) , QIAGEN. (Germany), F. Hoffmann-La Roche Ltd.
(Switzerland), Agilent Technologies Inc. (U.S.) , Quest Diagnostics Inc.
(U.S.), Merck & Co. Inc. (U.S.) , Hologic, Inc ( U.S)., BD (U.S.)
GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bristol-Myers Squibb (US),
Eli Lilly and Company (US), Pfizer, Inc. (US), and Genomic Health, Inc. (US),
bioMérieux SA (France), Astellas Pharma Inc. (Japan)
Market Drivers
·
Rising incidence of cancer is working as a
market driver for this market
·
Increasing use of cancer biomarkers in drug
discovery and development due to its ease of use and accurate results.
·
Due to increase in cancer cases there is
increase in demand for Biomarkers
Market Restraints
·
Unfavorable regulatory and reimbursement
scenario due to high cancer case regulatory has made strict norms.
·
High capital investment is required for
biomarker but benefit is low as compared to cost-
·
Technical issues
is very high at the time of
sample collection and storage this is working as a market restraint.
Primary Respondents
·
Demand Side: Doctors, Surgeons, Medical
Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations,
Associations, Insurers, Medical Payers, Healthcare Authorities, Universities,
Technological Writers, Scientists, Promoters, and Investors among others.
·
Supply Side: Product Managers, Marketing
Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory
Affairs Managers among others.
Make an Inquiry for Discount On this
Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-biomarkers-market
Segmentation: Global
Cancer Biomarkers Market
Global Cancer Biomarkers Market By Type (genetic biomarkers, protein biomarkers, other cancer
biomarkers)
Cancer type
(breast cancer, lung cancer, prostate cancer, colorectal cancer , blood cancer,
melanoma , ovarian cancer, liver cancer, stomach cancer, other cancer types )
Technology (
imaging technologies, omic technologies (proteomics, genomics, other omic
technologies), cytogenetics-based tests, immunoassays)
Applications (drug discovery
and development, personalized medicine, diagnostics, others)
Geography (North America, South America,
Europe, Asia-Pacific andMiddle East and Africa)
Reasons to Purchase
this Report
·
Current and future of Global cancer biomarkers
market outlook in the developed and emerging markets
·
The segment that is expected to dominate the
market as well as the segment which holds highest CAGR in the forecast period
·
Regions/Countries that are expected to witness
the fastest growth rates during the forecast period
·
The latest developments, market shares, and
strategies that are employed by the major market players
About Data Bridge
Market Research:
Data Bridge Market Research set forth itself as an
unconventional and neoteric Market research and consulting firm with
unparalleled level of resilience and integrated approaches. We are determined
to unearth the best market opportunities and foster efficient information for
your business to thrive in the market. Data Bridge Market Research provides
appropriate solutions to the complex business challenges and initiates an
effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
No comments:
Post a Comment